GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharmaresearch Bio Co Ltd (XKRX:217950) » Definitions » Stock Based Compensation

Pharmaresearch Bio Co (XKRX:217950) Stock Based Compensation : ₩657 Mil (TTM As of Dec. 2023)


View and export this data going back to 2015. Start your Free Trial

What is Pharmaresearch Bio Co Stock Based Compensation?

Pharmaresearch Bio Co's Stock Based Compensation for the six months ended in Dec. 2023 was ₩657 Mil. Its Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₩657 Mil.


Pharmaresearch Bio Co Stock Based Compensation Historical Data

The historical data trend for Pharmaresearch Bio Co's Stock Based Compensation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharmaresearch Bio Co Stock Based Compensation Chart

Pharmaresearch Bio Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation
Get a 7-Day Free Trial 2.92 - - 505.88 657.10

Pharmaresearch Bio Co Semi-Annual Data
Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Stock Based Compensation Get a 7-Day Free Trial 2.92 - - 505.88 657.10

Pharmaresearch Bio Co Stock Based Compensation Calculation

Stock Based Compensation is a way corporations use stock options to reward employees. It provides executives and employees the opportunity to share in the growth of the company and, if structured properly, can align their interests with the interests of the company's shareholders and investors, without burning the company's cash on hand.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Stock Based Compensation for the trailing twelve months (TTM) ended in Dec. 2023 was ₩657 Mil.


Pharmaresearch Bio Co Stock Based Compensation Related Terms

Thank you for viewing the detailed overview of Pharmaresearch Bio Co's Stock Based Compensation provided by GuruFocus.com. Please click on the following links to see related term pages.


Pharmaresearch Bio Co (XKRX:217950) Business Description

Traded in Other Exchanges
N/A
Address
641-3, Saimdang-ro, Gangwon-do, Gangneung-si, KOR, 13494
Pharmaresearch Bio Co Ltd is a Korea-based biopharmaceutical company. The company is engaged in the research and development, manufacturing, sale, and marketing of biopharmaceutical products. Its product is ReNTox Injections, and Clostridium Botulinum Toxin type A is in pipeline.

Pharmaresearch Bio Co (XKRX:217950) Headlines

No Headlines